Report cover image

Global Next-Generation Cancer Diagnostics Market 2022-2028

Publisher Gen Consulting Company
Published Mar 20, 2022
Length 78 Pages
SKU # GCC17092223

Description

Global Next-Generation Cancer Diagnostics Market 2022-2028

Cancer ranks as a leading cause of death and an important barrier to increasing life expectancy in every country of the world. Cancer's rising prominence as a leading cause of death partly reflects marked declines in mortality rates of stroke and coronary heart disease, relative to cancer, in many countries. Next-generation cancer diagnostics aim to promote prevention and early detection of cancer. Garnering a CAGR of 18.9% from 2022 to 2028, the global next-generation cancer diagnostics market is projected to reach worth of USD 19,777 million by 2028-end, according to a new report by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global next-generation cancer diagnostics market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the next-generation cancer diagnostics industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the technology, and region. The global market for next-generation cancer diagnostics can be segmented by technology: polymerase chain reaction (PCR), next-generation sequencing (NGS), others. The PCR segment held the largest share of the global next-generation cancer diagnostics market in 2021 and is anticipated to hold its share during the forecast period. Next-generation cancer diagnostics market is further segmented by region: Asia Pacific, Europe, North America, Rest of the World (RoW).

By technology:
  • polymerase chain reaction (PCR)
  • next-generation sequencing (NGS)
  • others
By region:
  • Asia Pacific
  • Europe
  • North America
  • Rest of the World (RoW)
The report also provides a detailed analysis of several leading next-generation cancer diagnostics market vendors that include Abbott Laboratories, Agilent Technologies, Inc., BGI Group, Danaher Corporation, Exact Sciences Corp. (Genomic Health, Inc.), F. Hoffmann-La Roche AG, Hologic, Inc., Illumina, Inc., Myriad Genetics, Inc., OPKO Health, Inc., QIAGEN N.V., Sysmex Corporation, Thermo Fisher Scientific Inc., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
  • To analyze and forecast the market size of the global next-generation cancer diagnostics market.
  • To classify and forecast the global next-generation cancer diagnostics market based on technology, region.
  • To identify drivers and challenges for the global next-generation cancer diagnostics market.
  • To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global next-generation cancer diagnostics market.
  • To identify and analyze the profile of leading players operating in the global next-generation cancer diagnostics market.
Why Choose This Report
  • Gain a reliable outlook of the global next-generation cancer diagnostics market forecasts from 2022 to 2028 across scenarios.
  • Identify growth segments for investment.
  • Stay ahead of competitors through company profiles and market data.
  • The market estimate for ease of analysis across scenarios in Excel format.
  • Strategy consulting and research support for three months.
  • Print authentication provided for the single-user license.

Table of Contents

78 Pages
PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY TECHNOLOGY
Polymerase chain reaction (PCR)
Next-generation sequencing (NGS)
Others
PART 6. MARKET BREAKDOWN BY REGION
Asia Pacific
Europe
North America
Rest of the World (RoW)
PART 7. KEY COMPANIES
Abbott Laboratories
Agilent Technologies, Inc.
BGI Group
Danaher Corporation
Exact Sciences Corp. (Genomic Health, Inc.)
F. Hoffmann-La Roche AG
Hologic, Inc.
Illumina, Inc.
Myriad Genetics, Inc.
OPKO Health, Inc.
QIAGEN N.V.
Sysmex Corporation
Thermo Fisher Scientific Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us